hemas holdings plc investor presentation q3, 2013/14

15
HEMAS HOLDINGS PLC Investor Presentation Q3 2013/14

Upload: hemas-holdings-plc

Post on 13-Jan-2015

1.930 views

Category:

Business


3 download

DESCRIPTION

Hemas Holdings PLC Investor Presentation Q3, 2013/14

TRANSCRIPT

Page 1: Hemas Holdings PLC Investor Presentation Q3, 2013/14

HEMAS HOLDINGS PLC

Investor PresentationQ3 2013/14

Page 2: Hemas Holdings PLC Investor Presentation Q3, 2013/14

Hemas Group: A SnapshotShare Price (As at 20.02.2014)

: Rs. 37.50

Market Capitalization : Rs. 19.3Bn

% of Total Market : 0.82%

PER : 9.84*

PBV : 1.48

No of Shares : 515Mn

Public Shareholding : 28.73%

Sept 2012 Dec 2012 Mar 2013 Jun 2013 Sept 2013 Dec 2013 -

5.0

10.0

15.0

20.0

25.0

30.0 Sector & Market PER vs Hemas PER

Diversified Sector PER

Market PER

Hemas PER

* PER based on annualized YTD Q3 earnings

Page 3: Hemas Holdings PLC Investor Presentation Q3, 2013/14

YTD Q3 2013/14

YTD Q3 2012/13

EPS* 3.81 2.76 38%

Net Assets per Share 25.39 21.62 17%

ROE* 16.2% 13.8%

ROCE* 14.5% 13.1%

% Change

Hemas Group: Performance Highlights

* Annualized based on YTD Q3 results

Figures are in Rs. MnYTD Q3 2013/14

YTD Q3 2012/13

Group Turnover 23,665 19,312 23%

Operating Profit 2,281 1,651 38%

Group Earnings 1,473 1,067 38%

Cash from Operations 2,279 375 507%

% Change

Figures are in Rs. MnYTD Q3 2013/14

31 March 2013

Total Assets 32,210 26,008 24%

Net Current Assets 4,160 4,156 0.1%

Shareholders’ Funds 13,084 12,153 8%

Capital Employed 23,754 19,339 23%

% Change

Page 4: Hemas Holdings PLC Investor Presentation Q3, 2013/14

Group Revenue Growth Exceeds 20%

• Group Revenue for the period ending 31st December 2013 was recorded at Rs. 23.6 Bn, a growth of 23%

• Revenue growth was driven by the Healthcare, FMCG and Transportation sectors

• New acquisitions, J.L Morison and Panasian power contributed Rs. 1,495Mn and Rs. 175Mn to Group Revenue respectively

YTD Q3 2009/10

YTD Q3 2010/11

YTD Q3 2011/12

YTD Q3 2012/13

YTD Q3 2013/14

0

5,000

10,000

15,000

20,000

25,000

-10%

-5%

0%

5%

10%

15%

20%

25%

30%

Group Revenue

Revenue Growth

Rs.Mn

Page 5: Hemas Holdings PLC Investor Presentation Q3, 2013/14

Underlying Earnings Grow by 19%

• Group Earnings for the period ending 31st December 2013 was reported at Rs. 1,473Mn, a growth of 38%

• Earnings growth was primarily driven by the capital gain of Rs. 375Mn recognized during the last quarter

• The underlying earnings growth adjusted for the capital gain, hotels closure and startup losses of Thalawathugoda hospital was 18.5%

YTD Q3 2009/10

YTD Q3 2010/11

YTD Q3 2011/12

YTD Q3 2012/13

YTD Q3 2013/14

0

200

400

600

800

1,000

1,200

1,400

1,600

-20%

-10%

0%

10%

20%

30%

40%

50%

60%

70%

Group Earnings

Earnings Growth

Rs.Mn

Page 6: Hemas Holdings PLC Investor Presentation Q3, 2013/14

Revenue and Earnings Composition

FMCG; 31%

Healthcare; 37%

Leisure; 4%

Transporta-tion; 5%

Power; 19%

Other; 5%FMCG; 38%

Healthcare; 29%

Leisure; 2%

Transporta-tion; 18%

Power; 13%

Revenue Composition Earnings Composition

“Other” segment – (7%)

Page 7: Hemas Holdings PLC Investor Presentation Q3, 2013/14

FMCG, Focused on Innovation

• FMCG sector posted a revenue of Rs. 7.2 Bn, a growth of 27%

• Revenue growth was led by the strong performance of personal wash and personal care categories

• Sector operating profits grew by 24% led by growth in volumes

• Profit after tax growth was impacted by the increased tax burden due to expiration of the tax holiday

• Dandex, Diva and PRO were re-launched during the quarter enhancing the customer appeal

2009/10

2010/11

2011/12 2012/13

2013/14

0

1,000,000

2,000,000

3,000,000

4,000,000

5,000,000

6,000,000

7,000,000

8,000,000

0

100,000

200,000

300,000

400,000

500,000

600,000

700,000

YTD Q3 Revenue and PAT

Revenue PAT

Rs.Mn Rs.Mn

YTD Q3 2013/14

YTD Q3 2012/13 % Change

Turnover (Rs.Mn) 7,237 5,706 27%

PAT (Rs.Mn) 607 567 7%

Page 8: Hemas Holdings PLC Investor Presentation Q3, 2013/14

Hemas Pharma Outperforms Market

2009/10 2010/11 2011/12 2012/13

2013/14

0

2,000,000

4,000,000

6,000,000

8,000,000

10,000,000

0

100,000

200,000

300,000

400,000

500,000

YTD Q3 Revenue and PAT

Revenue PAT

Rs.Mn Rs.Mn

• Healthcare sector revenue was Rs. 8.8Bn with a growth of 32%, driven by the Pharmaceuticals revenue which grew by 19%

• Hemas Pharmaceuticals reinforced its market leadership with an increased share of 19.2% (Source: IMS)

• The business acquired a 35,000 sqft. modern warehouse at Elakanda, Wattala to expand the storage capacity

• Hospitals revenue experienced a growth of 29%, boosted with the revenue from our new hospital, Thalawathugoda

• Healthcare sector profits were impacted by the startup losses of the new hospital

YTD Q3 2013/14

YTD Q3 2012/13 % Change

Turnover (Rs.Mn) 8,822 6,662 32%

PAT (Rs.Mn) 417 355 17%

Page 9: Hemas Holdings PLC Investor Presentation Q3, 2013/14

Hotels Geared up for the Winter

YTD Q3 2013/14

YTD Q3 2012/13 % Change

Turnover (Rs.Mn) 891 1,082 -18%

PAT (Rs.Mn) 20 207 -90%

2009/10

2010/11

2011/12

2012/13

2013/14

0

200,000

400,000

600,000

800,000

1,000,000

1,200,000

-50,000

0

50,000

100,000

150,000

200,000

250,000

YTD Q3 Revenue and PAT

Revenue PAT

Rs.Mn Rs.Mn

• Club Hotel Dolphin was re-opened after the refurbishment on 1st November 2013 and enjoys occupancy levels over 80%

• Leisure Sector revenue was negatively impacted during the 1st two quarters of the year due to the closure of the two key hotels for refurbishment

• All our four hotels received the ‘Travelife GOLD’ certification in recognition of the highest level of commitment towards sustainable tourism practices

• Avani Kalutara was awarded as the ‘Top Hotel 2014’ by Holiday check travel site

• All our hotels are geared up to close the year on a stronger note

Page 10: Hemas Holdings PLC Investor Presentation Q3, 2013/14

Container Yard Begins Operations

YTD Q3 2013/14

YTD Q3 2012/13 % Change

Turnover (Rs.Mn) 1,080 747 45%

PAT (Rs.Mn) 289 216 34%

2009/10 2010/11

2011/12

2012/13

2013/140

200,000

400,000

600,000

800,000

1,000,000

1,200,000

0

50,000

100,000

150,000

200,000

250,000

300,000

350,000

Revenue and PAT

Revenue PAT

Rs.Mn Rs.Mn

• Transportation sector revenue surpassed Rs. 1Bn mark posting an impressive growth of 45%

• Revenue growth was driven by the logistics and the aviation segments

• Maritime segment was positively impacted by the growth in transshipment volumes

• Sector operating profits grew by 25% to record at Rs. 335Mn

• Hemas Logistics declared open its first container yard at Welisara in November

• The container yard can store and service over 3000 TEUs at any time using state-of-the-art container handlers

Page 11: Hemas Holdings PLC Investor Presentation Q3, 2013/14

YTD Q3 2013/14

YTD Q3 2012/13 % Change

Turnover (Rs.Mn) 4,416 4,395 0.5%

PAT (Rs.Mn) 358 212 69%

2009/10

2010/11

2011/12

2012/13

2013/14

0

1,000,000

2,000,000

3,000,000

4,000,000

5,000,000

0

50,000

100,000

150,000

200,000

250,000

300,000

350,000

400,000

YTD Q3 Revenue and PAT

Revenue PAT

Rs.Mn Rs.Mn

• Power sector revenue growth was hindered by the thermal power generation curtailment imposed by the CEB

• Hydro power segment enjoyed a healthy period with increased rainfall in catchment areas and the increase in avoided-cost-tariff

• Hydro power revenue (excluding Panasian Power) grew by an impressive 89%

• Panasian Power contributed Rs. 175Mn to the sector revenue

• Sector operating profits grew by 56% to record Rs. 433Mn, for which Panasian Power contributed Rs. 129Mn

Healthy 9 Months for Hydro Power

Page 12: Hemas Holdings PLC Investor Presentation Q3, 2013/14

J.L Morison PAT Improves by 25%

YTD Q3 2013/14

YTD Q3 2012/13 % Change

Turnover (Rs.Mn) 1,905 2,163 -12%

PAT (Rs.Mn) 144 115 25%

2009/10 2010/11

2011/12

2012/13 2013/140

500,000

1,000,000

1,500,000

2,000,000

2,500,000

0

50,000

100,000

150,000

200,000

YTD Q3 Revenue and PAT

Revenue PAT

Rs.Mn Rs.Mn

• J.L Morison recorded a revenue of Rs. 1.9Bn for the 9 months with the revenue of Pharmaceuticals and Agro segments growing by 15% and 14% respectively

• Operating profit and profit after tax improved by 23% and 25% respectively despite the drop in overall revenue

• Profit growth was largely driven by the pharmaceuticals segment of which operating profit grew by 33%

• J.L Morison contributed 6% to the Group revenue and 8% to Group profit after tax

Page 13: Hemas Holdings PLC Investor Presentation Q3, 2013/14

Corporate Social Responsibility

• “Piyawara” brand ambassador, Mr. Roshan Mahanama came forward to build the 39th Piyawara community pre-school with his personal funds, in Veheratenna, south of Mullathivu

• Christmas gifts were collected from the Hemas staff and were distributed among children in Malhawa, Bibile and  Veheratanna, a resettled village in Welioya

• “Ape Sihiniya”, an exhibition to showcase the paintings and handicrafts of differently abled children from Hambantota Piyawara school was held at Hemas House on 9th and 10th of January 2014

Page 14: Hemas Holdings PLC Investor Presentation Q3, 2013/14

In Our Efforts of Going Green…• The environmental club of J.L Morison,

“Thuruliya Committee” greeted the new year by planting Mahogani trees in their premises

• The top management of Hemas appreciated and rewarded the staff at Dankotuwa Factory for maintaining over 3,500 plants of jak, mahagony, kohomba and maadang

• Hemas Green club embarked on a pilot project to produce compost with food waste at Hemas House canteen

• The club also organized a lecture by Mr. Srilal Mittapala, a well-known wildlife activist in Sri Lanka, on Udawalawe’s iconic tusker “The Walawe Raja” on 6th December 2013

Page 15: Hemas Holdings PLC Investor Presentation Q3, 2013/14

Telephone: +94 11 4 731 731Email: [email protected]

Web: http://www.hemas.com

Hemas Holdings PLC Hemas House, 75, Braybrooke Place, Colombo 2,

 Sri Lanka

Hemas Investor Relations: